Judith van de Wetering

Judith van de Wetering is a Researcher at Erasmus University Rotterdam, specifically within the Erasmus University Medical Center's Internal Medicine department. Her work focuses on kidney transplantation, with particular expertise in HLA antibodies, graft survival, and living donor transplantation outcomes.

Dr. van de Wetering's research spans several critical areas in transplantation medicine. She investigates how HLA mismatches affect graft survival and rejection, the impact of donor-specific antibodies on transplantation outcomes, and strategies to improve living donor kidney transplantation. Her work also explores the relationship between oxalic acid metabolism and kidney function, as well as innovative approaches to kidney exchange programs. Her fingerprint analysis reveals strong expertise in HLA-DRB1, HLA-DQB1, and antibody-mediated aspects of transplantation.

Analysis of her recent publication trends shows increasing focus on personalized approaches to immunosuppression and the development of algorithms to optimize donor-recipient matching. Her work bridges basic immunological research with clinical applications, contributing to evidence-based improvements in kidney transplantation protocols. She has been actively involved in multicenter clinical trials examining tacrolimus dosing and conversion to everolimus-based regimens.

Dr. van de Wetering collaborates extensively with researchers across multiple institutions, as evidenced by her participation in large-scale multicenter studies. Her research has practical implications for clinical practice, particularly in optimizing donor-recipient matching and immunosuppressive regimens to improve long-term graft survival. She has contributed significantly to understanding the complex interplay between donor-recipient immunological matching and long-term graft outcomes.